Edwards Lifesciences Net Income Growth Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 141.00  1.34  0.94%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Income Growth of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the growth in Net Income Common Stock over the specified period.
Net Income Growth  10 Years Trend  
Slightly volatile
 Net Income Growth 

Edwards Lifesciences Net Income Growth Over Time

2016-12-31 (0.39) 
2017-12-31 (0.39) 
2018-12-31 (0.46) 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  0.096677
Geometric Mean  0.28
Coefficient Of Variation  489.53
Mean Deviation  0.37
Median  0.08578
Standard Deviation  0.47
Sample Variance  0.22
Range  1.53
R Value (0.44)
Mean Square Error  0.20
R Squared  0.19
Significance  0.13
Slope (0.053163)
Total Sum of Squares  2.69

Currently Trending

Purchased over 90 shares of
few hours ago ago
Traded for 53.25
Purchased over 90 shares of
few hours ago ago
Traded for 31.26
Purchased over 90 shares of
few hours ago ago
Traded for 85.39